On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid
- PMID: 3021732
On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid
Abstract
The binding of tissue-type plasminogen activator (t-PA) to fibrin is mediated both by its finger domain and by its kringle-2 domain. In this report, we investigate the relative affinities of these domains for lysine. Human recombinant t-PA deletion-mutant proteins were prepared and their ability to bind to lysine-Sepharose was investigated. Mutants containing the kringle-2 domain bound to lysine-Sepharose, whereas mutants lacking this domain but containing the finger domain, the epidermal growth factor domain or the kringle-1 domain did not bind to lysine-Sepharose. Mutant proteins containing the kringle-2 domain could be specifically eluted from lysine-Sepharose with epsilon-amino caproic acid. This lysine derivative also abolished fibrin binding by the kringle-2 domain but had no effect on the fibrin-binding property of the finger domain. Thus, a lysine-binding site is involved in the interaction of the kringle-2 domain with fibrin but not in the interaction of the finger domain with fibrin. The implications of the nature of these two distinct interactions of t-PA with fibrin on plasminogen activation by t-PA will be discussed.
Similar articles
-
Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator.Protein Eng. 1995 Dec;8(12):1295-1302. doi: 10.1093/protein/8.12.1295. Protein Eng. 1995. PMID: 8869642
-
Functional properties of the recombinant kringle-2 domain of tissue plasminogen activator produced in Escherichia coli.J Biol Chem. 1990 Aug 25;265(24):14606-11. J Biol Chem. 1990. PMID: 2117612
-
Binding of tissue-type plasminogen activator to lysine, lysine analogues, and fibrin fragments.Biochemistry. 1989 Sep 5;28(18):7318-25. doi: 10.1021/bi00444a026. Biochemistry. 1989. PMID: 2510823
-
Structure and function of human tissue-type plasminogen activator (t-PA).J Cell Biochem. 1986;32(3):169-78. doi: 10.1002/jcb.240320302. J Cell Biochem. 1986. PMID: 3097031 Review.
-
Apolipoprotein(a): structure-function relationship at the lysine-binding site and plasminogen activator cleavage site.Biol Chem. 2002 Jan;383(1):93-9. doi: 10.1515/BC.2002.009. Biol Chem. 2002. PMID: 11928826 Review.
Cited by
-
Prediction of the three-dimensional structure of the enzymatic domain of t-PA.J Comput Aided Mol Des. 1988 Apr;2(1):7-14. doi: 10.1007/BF01532049. J Comput Aided Mol Des. 1988. PMID: 3143811
-
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.Am J Physiol Cell Physiol. 2021 Oct 1;321(4):C721-C734. doi: 10.1152/ajpcell.00269.2021. Epub 2021 Aug 18. Am J Physiol Cell Physiol. 2021. PMID: 34406905 Free PMC article. Review.
-
Mapping of the catalytic site of CHO-t-PA and the t-PA variant BM 06.022 by synthetic inhibitors and substrates.Protein Sci. 1992 Aug;1(8):1007-13. doi: 10.1002/pro.5560010806. Protein Sci. 1992. PMID: 1304379 Free PMC article.
-
Structural Biology and Protein Engineering of Thrombolytics.Comput Struct Biotechnol J. 2019 Jul 2;17:917-938. doi: 10.1016/j.csbj.2019.06.023. eCollection 2019. Comput Struct Biotechnol J. 2019. PMID: 31360331 Free PMC article. Review.
-
Delivery of thrombolytic therapy using rod-shaped plant viral nanoparticles decreases the risk of hemorrhage.Nanoscale. 2018 Sep 13;10(35):16547-16555. doi: 10.1039/c8nr02861c. Nanoscale. 2018. PMID: 30137088 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources